Alfasigma R&D presents a new inhalable antibody able to block COVID19
Developed by the researchers of Labio 4.0 of Pomezia and University of Rome Tor Vergata, it has been obtained from the blood of doctors of the Hospital of Bergamo infected during the pandemic emergen...
Read more